Homozygosity for the c.917A → T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz

Dermatology

Volumn 222, Issue 1, 2011, Pages 81-86

  Arnold, Andreas W ^a   Burger, Bettina ^b   Kump, Erwin ^b   Rufle, Alexander ^b   Tyring, Stephen K ^e   Kempf, Werner ^c,d   Häusermann, Peter ^a   Itin, Peter H ^a  

^a Universitatsspital Basel Dermatologie   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Kempf und Pfaltz   (Switzerland)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinogenesis; Epidermodysplasia; EVER; Gene; Genodermatosis; Human papillomavirus; Lewandowsky Lutz dysplasia; TMC

Indexed keywords

BLEOMYCIN; DNA; METHOTREXATE;

ADULT; ARTICLE; BETAPAPILLOMAVIRUS; CASE REPORT; CHROMOSOME 17Q; CHROMOSOME 2P; CLINICAL FEATURE; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER1 GENE; EVER2 GENE; FEMALE; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRON; NONHUMAN; PRIORITY JOURNAL; RADIOTHERAPY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN SURGERY; TMC6 GENE; TMC8 GENE;

AGED, 80 AND OVER; BETAPAPILLOMAVIRUS; CARCINOMA; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; EPIDERMODYSPLASIA VERRUCIFORMIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SIBLINGS; SKIN NEOPLASMS;

EID: 79951682408     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322536     Document Type: Article

References (40)

1. Itin PH, Lautenschlager S: Genodermatosis with reticulate, patchy and mottled pigmentation of the neck: a clue to rare dermatologic disorders. Dermatology 1998;197:281-290. (Pubitemid 28445836)
2. Orth G: Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006;18:362-374. (Pubitemid 44511885)
3. Storey A: Papillomaviruses: death-defying acts in skin cancer. Trends Mol Med 2002;8:417-421. (Pubitemid 34975987)
4. Lutzner MA: Epidermodysplasia verruciformis: an autosomal recessive disease characterized by viral warts and skin cancer - a model for viral oncogenesis. Bull Cancer 1978;65:169-182.
5. Ramoz N, Taieb A, Rueda LA, Montoya LS, Bouadjar B, Favre M, Orth G: Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000;114:1148-1153. (Pubitemid 30415231)
6. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M: Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002;32:579-581. (Pubitemid 35435168)
7. Keresztes G, Mutai H, Heller S: TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 2003;4:24.
8. Kurima K, Yang Y, Sorber K, Griffith AJ: Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003;82:300-308. (Pubitemid 36952303)
9. 2+ ions in host-virus interactions. J Virol 2008;82:11486-11494.
10. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M: Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomav iruses. J Exp Med 2008;205:35-42. (Pubitemid 351185713)
11. Lewandowsky F, Lutz W: Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch Dermatol Syph 1922;141:193-203.
12. Fuchs H: Ein Fall von eigenartiger Dyskeratose (Epidermodysplasia verruciformis). Arch Dermatol Syph 1922;141:225-231.
13. Lutz W: A propos de l'epidermodysplasie verruciforme. Dermatologica 1946;92:30-43.
14. Häusermann P, Lutter S, Meigel W, Rufli T: Das Lewandowsky-Lutz- Syndrom: Die Erstbeschreibung und drei weitere Basler Fälle der Epidermodysplasia verruciformis. Z Hautkr 2002;77:176-180. (Pubitemid 34461324)
15. Jablonska S, Milewski B: Zur Kenntnis der Epidermodysplasia verruciformis Lewandowsky-Lutz. Dermatologica 1957;115:1-22.
16. Berthelot C, Dickerson MC, Rady P, He Q, Niroomand F, Tyring SK, Pandya AG: Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol 2007;56:882-886. (Pubitemid 46561022)
17. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-477.
18. Husnjak K, Grce M, Magdic L, Pavelic K: Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 2000;88:125-134.
19. Harwood CA, Spink PJ, Surentheran T, Leigh IM, de Villiers EM, McGregor JM, Proby CM, Breuer J: Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999;37:3545-3555. (Pubitemid 29491090)
20. Patel AS, Karagas MR, Pawlita M, Waterboer T, Nelson HH: Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a casecontrol study. Int J Cancer 2008;122:2377-2379. (Pubitemid 351542345)
21. Hohenstein E, Rady PL, Hergersberg M, Huber AR, Tyring SK, Bregenzer T, Streit M, Itin P: Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A → T polymorphism in the TMC8/EVER2 gene. Dermatology 2009;218:114-118.
22. Jablonska S, Dabrowski J, Jakubowicz K: Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972;32:583-589.
23. Donfack J, Buchinsky FJ, Derkay CS, Steinberg BM, Choi SS, Conley SF, Meyer CM 3rd, McClay JE, Campisi P, Hu FZ, Preston RA, Abramson AL, Ehrlich GD, Post JC: Four mutations in epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP. Int J Pediatr Otorhinolaryngol 2006;70:1235-1240.
24. Gober MD, Rady PL, He Q, Tucker SB, Tyring SK, Gaspari AA: Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J Invest Dermatol 2007;127:817-820. (Pubitemid 46434656)
25. Aochi S, Nakanishi G, Suzuki N, Setsu N, Suzuki D, Aya K, Iwatsuki K: A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. Br J Dermatol 2007;157:1265-1266. (Pubitemid 350115685)
26. Zuo YG, Ma D, Zhang Y, Qiao J, Wang B: Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J Dermatol Sci 2006;44:153-159.
27. Tate G, Suzuki T, Kishimoto K, Mitsuya T: Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 2004;49:223-225. (Pubitemid 38657572)
28. Sun XK, Chen JF, Xu AE: A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 2005;30:573-574.
29. Orth G: Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol 2008;321:59-83.
30. http://www.ncbi.nlm.nih.gov/SNP/snp-ref.cgi?rs=7208422.
31. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004;101:6062-6067. (Pubitemid 38520528)
32. Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M: The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 2009;73:348-370.
33. Androphy EJ, Dvoretzky I, Lowy DR: X-linked inheritance of epidermodysplasia verruciformis: genetic and virologic studies of a kindred. Arch Dermatol 1985;121:864-868. (Pubitemid 15070196)
34. McDermott DF, Gammon B, Snijders PJ, Mbata I, Phifer B, Howland Hartley A, Lee CC, Murphy PM, Hwang ST: Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. Pediatr Dermatol 2009;26:306-310.
35. Tanigaki T, Kanda R, Sato K: Epidermodysplasia verruciformis (L-L, 1922) in a patient with systemic lupus erythematosus. Arch Dermatol Res 1986;278:247-248. (Pubitemid 16106528)
36. Gross G, Ellinger K, Roussaki A, Fuchs PG, Peter HH, Pfister H: Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 1988;91:43-48.
37. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JA: Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989;ii:224-225.
38. Hultgren TL, Srinivasan SK, DiMaio DJ: Epidermodysplasia verruciformis occurring in a patient with human immunodeficiency virus: a case report. Cutis 2007;79:307-311.
39. Lutzner M, Croissant O, Ducasse MF, Kreis H, Crosnier J, Orth G: A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol 1980;75:353-356. (Pubitemid 10024621)
40. Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, Engler DE, Grossman ME: Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 2009;60:315-320.